Concepedia

Kathy L. Kohlhaas

KL

Statistics

Publications

30

Citations

1.7K

H-Index

22

Active since

1992

Affiliations

Abbott Fund(Current)

Abbott (United Kingdom)

Abbott (United States)

AbbVie (United States)

NeuroSearch (Denmark)

Kathy L. Kohlhaas is an author at Abbott Fund specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1992–2019

30

Publications

30

An Allosteric Modulator of the α7 Nicotinic Acetylcholine Receptor Possessing Cognition-Enhancing Properties in Vivo

Daniel B. Timmermann, Jens Halvard Grønlien, Kathy L. Kohlhaas et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 214 citations

eIF2B activator prevents neurological defects caused by a chronic integrated stress response

Yao Liang Wong, Lauren LeBon, Ana M. Basso et al. · eLife · 2019 · 214 citations · Full text

, , +18

Induction by endotoxin of nitric oxide synthase in the rat mesentery: lack of effect on action of vasoconstrictors

Jane A. Mitchell, Kathy L. Kohlhaas, Raffaella Sorrentino et al. · British Journal of Pharmacology · 1993 · 134 citations · Full text

Augmentation of cognitive function by NS9283, a stoichiometry‐dependent positive allosteric modulator of α2‐ and α4‐containing nicotinic acetylcholine receptors

D.B. Timmermann, Karin Sandager‐Nielsen, Tino Dyhring et al. · British Journal of Pharmacology · 2012 · 104 citations

In Vivo Pharmacological Characterization of a Novel Selective α7 Neuronal Nicotinic Acetylcholine Receptor Agonist ABT-107: Preclinical Considerations in Alzheimer's Disease

Robert S. Bitner, William H. Bunnelle, Michael Decker et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 96 citations

1–5 of 30